#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

A 50-Year-Old Man with Deteriorating Cognitive Function and Impaired Movement


article has not abstract


Vyšlo v časopise: A 50-Year-Old Man with Deteriorating Cognitive Function and Impaired Movement. PLoS Med 6(1): e19. doi:10.1371/journal.pmed.1000019
Kategorie: Learning Forum
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000019

Souhrn

article has not abstract


Zdroje

1. American Psychiatric Association

2000

Diagnostic and statistical manual of mental disorders

4th edition

text revision (DSM-IV-TR)

Washington (D. C.)

American Psychiatric Association

943

2. DoranM

1997

Diagnosis of presenile dementia.

Br J Hosp Med

58

105

110

3. MendezMF

2006

The accurate diagnosis of early-onset dementia.

Int J Psychiatry Med

36

401

412

4. RatnavalliEBrayneCDawsonKHodgesJR

2002

The prevalence of frontotemporal dementia.

Neurology

58

1615

1621

5. HodgesJR

editor

2007

Frontotemporal dementia syndromes

Cambridge (UK)

Cambridge University Press

346

6. VarmaARSnowdenJSLloydJJTalbotPRMannDM

1999

Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia.

J Neurol Neurosurg Psychiatry

66

184

188

7. LarnerAJ

2008

Neuropsychological neurology: The neurocognitive impairments of neurological disorders

Cambridge (UK)

Cambridge University Press

248

8. McKhannGDrachmanDFolsteinMKatzmanRPriceD

1984

Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task forces on Alzheimer's disease.

Neurology

34

939

944

9. CrutsMvan DuijnCMBackhovensHVan den BroeckMWehnertA

1998

Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease.

Hum Mol Genet

7

43

51

10. GauthierSEmreMFarlowMRBullockRGrossbergGT

2003

Strategies for continued successful treatment of Alzheimer's disease: Switching cholinesterase inhibitors.

Curr Med Res Opin

19

707

714

11. LitvanIAgidYCalneDCampbellGDuboisB

1996

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop.

Neurology

47

1

9

12. FosterNLWilhelmsenKSimaAAJonesMZD'AmatoCJ

1997

Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference.

Ann Neurol

41

706

715

13. Johns Hopkins University

2008

Online Mendelian inheritance in man.

Available: http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim. Accessed 15 December 2008

14. BakTHHodgesJR

1998

The neuropsychology of progressive supranuclear palsy.

Neurocase

4

89

98

15. TsuboiYJosephsKACooksonNDicksonDW

2003

APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.

Neurology

60

240

245

16. UrasakiKKurikiKNamerikawaMSatohSIkeguchiK

2000

An autopsy case of Alzheimer's disease with a progressive supranuclear palsy overlap.

Neuropathology

20

233

238

17. KasahataNAraiNMakitaY

2008

An Alzheimer disease with dementia with Lewy bodies patient presenting progressive supranuclear palsy-like clinical manifestations and radiological atrophy of midbrain tegmentum. A clinical and neuropathological study.

J Neurol

255

Suppl 2

196

18. BoeveBFDicksonDDuffyJBartlesonJTrenerryM

2003

Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology.

Eur Neurol

49

72

78

19. MochizukiAUedaYKomatsuzakiYTsuchiyaKAraiT

2003

Progressive supranuclear palsy presenting with primary progressive aphasia—Clinicopathological report of an autopsy case.

Acta Neuropathol

105

610

614

20. University of Antwerp Molecular Genetics Department

2008

Alzheimer disease and frontotemporal dementia mutation database.

Available: http://www.molgen.ua.ac.be/Admutations/. Accessed 15 December 2008

21. DoranMdu PlessisDGGhadialiEJMannDMAPickering-BrownS

2007

Familial early-onset dementia with tau intron 10 +16 mutation with clinical features similar to those of Alzheimer disease.

Arch Neurol

64

1535

1539

22. LarnerAJ

2008

Mutation negative “early-onset familial Alzheimer's disease”: Consider screening for tau gene mutations.

Alzheimer Dis Assoc Disord

22

194

195

23. MorrisHROsakiYHoltonJLeesAJWoodNW

2003

Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP.

Neurology

61

102

104

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2009 Číslo 1
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#